|
SMAD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62814206561279E-12 |
| Normal-vs-Stage2 |
3.15140025186622E-10 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.928400E-01 |
| Stage1-vs-Stage3 |
5.169600E-01 |
| Stage1-vs-Stage4 |
2.847500E-02 |
| Stage2-vs-Stage3 |
2.134600E-01 |
| Stage2-vs-Stage4 |
1.275910E-02 |
| Stage3-vs-Stage4 |
1.294620E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.66133814775094E-16 |
| Normal-vs-AfricanAmerican |
1.06840000180242E-08 |
| Normal-vs-Asian |
4.63920013515917E-10 |
| Caucasian-vs-AfricanAmerican |
6.263000E-01 |
| Caucasian-vs-Asian |
1.765840E-01 |
| AfricanAmerican-vs-Asian |
6.658200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
5.285200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.66533453693773E-15 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(81-100Yrs) |
1.661660E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.012000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.518800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.481800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.218600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.345800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.144000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.064790E-01 |
| Classical-VS-Follicular |
9.848000E-01 |
| Classical-VS-Other |
2.829200E-01 |
| Classical-VS-Normal |
7.26085858104852E-14 |
| Tall-VS-Follicular |
1.602780E-01 |
| Tall-VS-Other |
8.027600E-01 |
| Tall-VS-Normal |
1.8286483438601E-12 |
| Follicular-VS-Other |
3.290600E-01 |
| Follicular-VS-Normal |
1.63857816204427E-12 |
| Other-VS-Normal |
3.84920000000566E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
4.59632332194815E-14 |
| N0-vs-N1 |
2.951800E-01 |
|
|
